HOME > BUSINESS > Article

Text Size

small

medium

large


Scandal-Hit Kobayashi Pharma Withdraws 2024 Earnings Forecasts

Scandal-Hit Kobayashi Pharma Withdraws 2024 Earnings Forecasts

   Osaka, May 10 (Jiji Press)--Kobayashi Pharmaceutical Co. on Friday withdrew its consolidated earnings forecasts for the business year to December 2024, citing difficulties in assessing the impact of a scandal involving its supplement products containing "beni koji" red fermented rice.
   For the January-March quarter, the company booked an extraordinary loss of 3,862 million yen related to the beni koji scandal, in which health problems spread among users of its supplement products.

To read a full story, please click here to find out how to subscribe.

BUSINESS

HEADLINES

POLITICS
Japan's LDP Submits Bill to Revise Political Funds Control Law to Parliament
ECONOMY
Over 60% of Japanese Firms See Weak Yen Squeeze Profits: Teikoku Databank Survey
SPORTS
Sumo: Ozeki Hoshoryu Improves to 4-2 with Win over Tobizaru at Summer Tournament
OTHER
Massachusetts Teen Died from Eating Spicy Chip at Social Media Event: Autopsy

AFP-JIJI PRESS NEWS JOURNAL


Photos